Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.

2018 ; Vol.28-1: 165~174

AuthorHyungtaek Jeon, Yun Hee Kang, Seung-Min Yoo, Myung-Jin Park, Jong Bae Park, Seung-Hoon Lee, Myung-Shin Lee
Place of dutyDepartment of Microbiology and Immunology, Eulji University School of Medicine, Daejeon 34824, Republic of Korea
TitleKaposi’s Sarcoma-Associated Herpesvirus Infection Modulates the Proliferation of Glioma Stem-Like Cells
PublicationInfo J. Microbiol. Biotechnol.2018 ; Vol.28-1
AbstractGlioblastoma multiforme is the most lethal malignant brain tumor. Despite many intensive studies, the prognosis of glioblastoma multiforme is currently very poor, with a median overall survival duration of 14 months and 2-year survival rates of less than 10%. Although viral infections have been emphasized as potential cofactors, their influences on pathways that support glioblastoma progression are not known. Some previous studies indicated that human Kaposi’s sarcoma-associated herpesvirus (KSHV) was detected in healthy brains, and its microRNA was also detected in glioblastoma patients’ plasma. However, a direct link between KSHV infection and glioblastoma is currently not known. In this study, we infected glioblastoma cells and glioma stem-like cells (GSCs) with KSHV to establish an in vitro cell model for KSHV-infected glioblastoma cells and glioma stem-like cells in order to identify virologic outcomes that overlap with markers of aggressive disease. Latently KSHV-infected glioblastoma cells and GSCs were successfully established. Additionally, using these cell models, we found that KSHV infection modulates the proliferation of glioma stem-like cells.
Full-Text
Key_wordKSHV, HHV-8, glioblastoma, glioma stem-like cell, proliferation
References
  1. Wen PY, Kesari S. 2008. Malignant gliomas in adults. N Engl. J. Med. 359: 492-507.
    Pubmed CrossRef
  2. Nieder C, Grosu AL, Astner S, Molls M. 2005. Treatment of unresectable glioblastoma multiforme. Anticancer Res. 25:4605-4610.
    Pubmed
  3. Huse JT, Holland EC. 2010. Targeting brain cancer:advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 10: 319-331.
    Pubmed CrossRef
  4. Filatova A, Acker T, Garvalov BK. 2013. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim. Biophys. Acta 1830: 2496-2508.
    Pubmed CrossRef
  5. Neman J, Jandial R. 2010. Decreasing glioma recurrence through adjuvant cancer stem cell inhibition. Biologics 4:157-162.
    CrossRef
  6. Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, et al. 2010. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer 10: 384.
    Pubmed CrossRef Pubmed Central
  7. Zhou ZH, Ping YF, Yu SC, Yi L, Yao XH, Chen JH, et al. 2009. A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. Cancer Lett. 281: 92-99.
    Pubmed CrossRef
  8. Vidone M, Alessandrini F, Marucci G, Farnedi A, de Biase D, Ricceri F, et al. 2014. Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme. Neuro Oncol. 16: 298-302.
    Pubmed CrossRef Pubmed Central
  9. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. 2012. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J. Virol. 86: 854-864.
    Pubmed CrossRef Pubmed Central
  10. Hawkins C, Croul S. 2011. Viruses and human brain tumors:cytomegalovirus enters the fray. J. Clin. Invest. 121: 3831-3833.
    Pubmed CrossRef Pubmed Central
  11. Ganem D . 2010. KSHV a nd t he p athogenesis o f Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120: 939-949.
    Pubmed CrossRef Pubmed Central
  12. Chan PK, Ng HK, Cheung JL, Cheng AF. 2000. Survey for the presence and distribution of human herpesvirus 8 in healthy brain. J. Clin. Microbiol. 38: 2772-2773.
    Pubmed Pubmed Central
  13. Merelli E, Bedin R, Sola P, Barozzi P, Mancardi GL, Ficarra G, et al. 1997. Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J. Neurol. 244: 450-454.
    Pubmed CrossRef
  14. Op sahl M L, K ennedy PG. 2 006. I nvestigating the p resence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J. Neurol. Sci. 240: 37-44.
    Pubmed CrossRef
  15. Jha HC, Mehta D, Lu J, El-Naccache D, Shukla SK, Kovacsics C, et al. 2015. Gammaherpesvirus infection of human neuronal cells. MBio 6: e01844-e01815.
    Pubmed CrossRef Pubmed Central
  16. Cho HJ, Song MJ. 2014. A gammaherpesvirus establishes persistent infection in neuroblastoma cells. Mol. Cells 37:518-525.
    Pubmed CrossRef Pubmed Central
  17. Herman A, Gruden K, Blejec A, Podpecan V, Motaln H, Rozman P, et al. 2015. Analysis of glioblastoma patients’ plasma revealed the presence of microRNAs with a prognostic impact on survival and those of viral origin. PLoS One 10: e0125791.
    Pubmed CrossRef Pubmed Central
  18. Lee MS, Yuan H, Jeon H, Zhu Y, Yoo S, Shi S, et al. 2016. Human mesenchymal stem cells of diverse origins support persistent infection with Kaposi’s sarcoma-associated herpesvirus and manifest distinct angiogenic, invasive, and transforming phenotypes. MBio 7: e02109-e02115.
    CrossRef
  19. Yoo SM, Ahn AK, Seo T, Hong HB, Chung MA, Jung SD, et al. 2008. Centrifugal enhancement of Kaposi’s sarcomaassociated virus infection of human endothelial cells in vitro. J. Virol. Methods 154: 160-166.
    Pubmed CrossRef
  20. Lee J, Jeon H, Yoo SM, Park J, Lee MS. 2016. The role of Kaposi’s sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells. Tumour Biol. 37:2587-2596.
    Pubmed CrossRef
  21. Lee MS, Jones T, Song DY, Jang JH, Jung JU, Gao SJ. 2014. Exploitation of the complement system by oncogenic Kaposi’s sarcoma-associated herpesvirus for cell survival and persistent infection. PLoS Pathog. 10: e1004412.
    Pubmed CrossRef Pubmed Central
  22. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
    CrossRef
  23. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. 2006. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
    Pubmed CrossRef
  24. Yoo S, Jang J, Kim S, Cho H, Lee MS. 2012. Expression of DcR3 and its effects in Kaposi’s sarcoma-associated herpesvirusinfected human endothelial cells. Intervirology 55: 45-52.
    Pubmed CrossRef
  25. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. 2008. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 116: 79-86.
    Pubmed CrossRef Pubmed Central
  26. Chi J, Gu B, Zhang C, Peng G, Zhou F, Chen Y, et al. 2012. Human herpesvirus 6 latent infection in patients with glioma. J. Infect. Dis. 206: 1394-1398.
    Pubmed CrossRef
  27. Yin J, Park G, Kim TH, Hong JH, Kim YJ, Jin X, et al. 2015. Pigment epithelium-derived factor (PEDF) expression induced by EGFRvIII promotes self-renewal and tumor progression of glioma stem cells. PLoS Biol. 13: e1002152.
    Pubmed CrossRef Pubmed Central
  28. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, et al. 2013. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl. Acad. Sci. USA 110: 8644-8649.
    Pubmed CrossRef Pubmed Central
  29. Prasad A, Lu M, Lukac DM, Zeichner SL. 2012. An alternative Kaposi’s sarcoma-associated herpesvirus replication program triggered by host cell apoptosis. J. Virol. 86: 4404-4419.
    Pubmed CrossRef Pubmed Central
  30. Li W, Jia X, Shen C, Zhang M, Xu J, Shang Y, et al. 2016. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. Oncotarget 7: 32286-32305.
    CrossRef



Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang.co., Ltd